Clinical Trials Logo

Clinical Trial Summary

This study will analyze whether dairy in combination with creatine supplementation will positively impact loading exercise-induced bone cell activity in healthy young females more than dairy and exercise or exercise alone.


Clinical Trial Description

Introduction: Two million individuals at a cost of around 2.3 billion dollars a year in Canada suffer from osteoporosis. Research that emphasizes the treatment of this disease is important, but so is research that focuses on prevention; reducing bone loss and/or increasing bone mass when young. Countermeasures to improve bone health, such as nutrition and exercise, should be explored and implemented, particularly during young adulthood when peak bone mass is achieved so that the burden of osteoporosis later in life can be mitigated. The proposed research combines both nutrition and exercise along with the assessment of bone turnover markers in healthy young females, and aims to determine whether dairy in combination with creatine supplementation positively impacts acute bone turnover following a bout of resistance and plyometric exercise.

Design: Randomized triple crossover trial.

Participants: 10 healthy university aged females.

Methods: Participants will be asked to complete 3 different acute exercise and nutritional supplement trials. Each trial will be assigned in random order. The three trials are: 1) exercise+carbohydrate (CHO), 2) exercise+milk (Milk), and 3) exercise+milk+creatine (Cre). The whole study will take a maximum of 12 weeks to complete as each supplement trial will be separated by 2-4 weeks. Each treatment is outlined below.

Anticipated Results: The investigators anticipate that creatine in conjunction with dairy and exercise will have a greater positive impact on acute bone cell activity in healthy young females more than dairy+exercise and more than exercise alone. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03615989
Study type Interventional
Source Brock University
Contact Andrea Josse, PhD
Phone 1 905-688-5550
Email ajosse@brocku.ca
Status Not yet recruiting
Phase N/A
Start date September 2018
Completion date January 2019

See also
  Status Clinical Trial Phase
Terminated NCT00001844 - Study of New Magnetic Resonance Methods
Completed NCT03160261 - Effect of Exenatide on Cortisol Secretion Phase 4
Recruiting NCT03662100 - A Study of Two Formulations of LY3074828 in Healthy Participants Phase 1
Recruiting NCT02875301 - Investigating Gains in Neurocognition in an Intervention Trial of Exercise Phase 3
Recruiting NCT03670082 - Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State Phase 1
Recruiting NCT03656952 - A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers Phase 1
Completed NCT03203824 - The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals N/A
Completed NCT03056846 - Probiotics on Stress-associated Gastrointestinal Function in University Students N/A
Recruiting NCT03114839 - Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN) N/A
Completed NCT03224702 - First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers Phase 1
Completed NCT03259464 - This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated Phase 1
Completed NCT03309566 - Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir Phase 4
Completed NCT00526916 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Phase 1
Completed NCT00527579 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Phase 1
Completed NCT03373162 - Functional Effects of Botox on the Brain Using MRS and fMRI Phase 4
Active, not recruiting NCT02509494 - Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 Phase 3
Terminated NCT02555085 - Single Ascending Doses of BIIB063 in Healthy Volunteers Phase 1
Completed NCT03125018 - Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX) N/A
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT00004556 - The Effects of Dextroamphetamine on Brain Function